BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Wu J, Contratto M, Shanbhogue KP, Manji GA, O’Neil BH, Noonan A, Tudor R, Lee R. Evaluation of a locked nucleic acid form of antisense oligo targeting HIF-1α in advanced hepatocellular carcinoma. World J Clin Oncol 2019; 10(3): 149-160 [PMID: 30949444 DOI: 10.5306/wjco.v10.i3.149]
URL: https://www.wjgnet.com/1007-9327/full/v10/i3/149.htm
Number Citing Articles
1
Chengheng Liao, Qing Zhang. Understanding the Oxygen-Sensing Pathway and Its Therapeutic Implications in DiseasesThe American Journal of Pathology 2020; 190(8): 1584 doi: 10.1016/j.ajpath.2020.04.003
2
Maxwell Shulman, Rachel Shi, Qing Zhang. Von Hippel-Lindau tumor suppressor pathways & corresponding therapeutics in kidney cancerJournal of Genetics and Genomics 2021; 48(7): 552 doi: 10.1016/j.jgg.2021.05.016
3
Vincent Wai-Hin Yuen, Carmen Chak-Lui Wong. Hypoxia-inducible factors and innate immunity in liver cancerJournal of Clinical Investigation 2020; 130(10): 5052 doi: 10.1172/JCI137553
4
Kurt Sartorius, Samuel O. Antwi, Anil Chuturgoon, Lewis R. Roberts, Anna Kramvis. RNA Therapeutic Options to Manage Aberrant Signaling Pathways in Hepatocellular Carcinoma: Dream or Reality?Frontiers in Oncology 2022; 12 doi: 10.3389/fonc.2022.891812
5
Zhen Luo, Mingfu Tian, Ge Yang, Qiaoru Tan, Yubing Chen, Geng Li, Qiwei Zhang, Yongkui Li, Pin Wan, Jianguo Wu. Hypoxia signaling in human health and diseases: implications and prospects for therapeuticsSignal Transduction and Targeted Therapy 2022; 7(1) doi: 10.1038/s41392-022-01080-1
6
Roy Elias, Qing Zhang, James Brugarolas. The von Hippel-Lindau Tumor Suppressor GeneThe Cancer Journal 2020; 26(5): 390 doi: 10.1097/PPO.0000000000000480
7
Zhenli Li, Mingda Zhao, Xingshun Qi, Yufu Tang, Shuqun Cheng. Mechanisms of portal vein tumour thrombus formation and development in patients with hepatocellular carcinomaJournal of Cellular and Molecular Medicine 2023; 27(15): 2103 doi: 10.1111/jcmm.17808
8
Kanchan Vishnoi, Navin Viswakarma, Ajay Rana, Basabi Rana. Transcription Factors in Cancer Development and TherapyCancers 2020; 12(8): 2296 doi: 10.3390/cancers12082296
9
Jianping Wang, Bin Zhao, Jingmin Che, Peng Shang. Hypoxia Pathway in Osteoporosis: Laboratory Data for Clinical ProspectsInternational Journal of Environmental Research and Public Health 2023; 20(4): 3129 doi: 10.3390/ijerph20043129
10
Sajad Fakhri, Seyed Zachariah Moradi, Farahnaz Faraji, Leila Kooshki, Kassidy Webber, Anupam Bishayee. Modulation of hypoxia-inducible factor-1 signaling pathways in cancer angiogenesis, invasion, and metastasis by natural compounds: a comprehensive and critical reviewCancer and Metastasis Reviews 2024; 43(1): 501 doi: 10.1007/s10555-023-10136-9
11
S. Bardaweel, S. A. Banihani, E. Al-Barghouthy. Biomarkers of Oxidative Stress2024; : 309 doi: 10.1007/978-3-031-69962-7_13
12
Xiaoyu Sun, Xuemei Lv, Yuanyuan Yan, Yanyun Zhao, Rong Ma, Miao He, Minjie Wei. Hypoxia-mediated cancer stem cell resistance and targeted therapyBiomedicine & Pharmacotherapy 2020; 130: 110623 doi: 10.1016/j.biopha.2020.110623
13
Mohammed Hussein Assi. Hypoxia-inducible Factors: Molecular Basis and Clinical ImplicationsMustansiriya Medical Journal 2023; 22(2): 161 doi: 10.4103/mj.mj_38_23
14
Gulnihal Ozcan. The hypoxia-inducible factor-1α in stemness and resistance to chemotherapy in gastric cancer: Future directions for therapeutic targetingFrontiers in Cell and Developmental Biology 2023; 11 doi: 10.3389/fcell.2023.1082057
15
David Roig-Carles, Holly Jackson, Katie F. Loveson, Alan Mackay, Rebecca L. Mather, Ella Waters, Massimiliano Manzo, Ilaria Alborelli, Jon Golding, Chris Jones, Helen L. Fillmore, Francesco Crea. The Long Non-Coding RNA H19 Drives the Proliferation of Diffuse Intrinsic Pontine Glioma with H3K27 MutationInternational Journal of Molecular Sciences 2021; 22(17): 9165 doi: 10.3390/ijms22179165
16
Ruixue Bai, Yunong Li, Lingyan Jian, Yuehui Yang, Lin Zhao, Minjie Wei. The hypoxia-driven crosstalk between tumor and tumor-associated macrophages: mechanisms and clinical treatment strategiesMolecular Cancer 2022; 21(1) doi: 10.1186/s12943-022-01645-2
17
Shant Qinxiang Sin, Chakrabhavi Dhananjaya Mohan, Robby Miguel Wen-Jing Goh, Mingliang You, Siddaiah Chandra Nayak, Lu Chen, Gautam Sethi, Kanchugarakoppal Subbegowda Rangappa, Lingzhi Wang. Hypoxia signaling in hepatocellular carcinoma: Challenges and therapeutic opportunitiesCancer and Metastasis Reviews 2023; 42(3): 741 doi: 10.1007/s10555-022-10071-1
18
Xin Wang, Zhen-wu Du, Tian-min Xu, Xiao-jun Wang, Wei Li, Jia-li Gao, Jing Li, He Zhu. HIF-1α Is a Rational Target for Future Ovarian Cancer TherapiesFrontiers in Oncology 2021; 11 doi: 10.3389/fonc.2021.785111
19
Corbin C. Jensen, Noel A. Warfel. Comprehensive Pharmacology2022; : 438 doi: 10.1016/B978-0-12-820472-6.00039-6
20
Cemre Ucaryilmaz Metin, Gulnihal Ozcan. The HIF-1α as a Potent Inducer of the Hallmarks in Gastric CancerCancers 2022; 14(11): 2711 doi: 10.3390/cancers14112711
21
Anne Noonan, Timothy M. Pawlik. Hepatocellular carcinoma: an update on investigational drugs in phase I and II clinical trialsExpert Opinion on Investigational Drugs 2019; 28(11): 941 doi: 10.1080/13543784.2019.1677606
22
Manish Pandey, Divya Ojha, Sakshi Bansal, Ambadas B. Rode, Geetanjali Chawla. From bench side to clinic: Potential and challenges of RNA vaccines and therapeutics in infectious diseasesMolecular Aspects of Medicine 2021; 81: 101003 doi: 10.1016/j.mam.2021.101003
23
Prithi Raguraman, Akilandeswari Ashwini Balachandran, Suxiang Chen, Sarah D. Diermeier, Rakesh N. Veedu. Antisense Oligonucleotide-Mediated Splice Switching: Potential Therapeutic Approach for Cancer MitigationCancers 2021; 13(21): 5555 doi: 10.3390/cancers13215555
24
Xiaoyi Yuan, Wei Ruan, Bentley Bobrow, Peter Carmeliet, Holger K. Eltzschig. Targeting hypoxia-inducible factors: therapeutic opportunities and challengesNature Reviews Drug Discovery 2024; 23(3): 175 doi: 10.1038/s41573-023-00848-6
25
Yang Liu, Ruyi Xu, Huiyao Gu, Enfan Zhang, Jianwei Qu, Wen Cao, Xi Huang, Haimeng Yan, Jingsong He, Zhen Cai. Metabolic reprogramming in macrophage responsesBiomarker Research 2021; 9(1) doi: 10.1186/s40364-020-00251-y
26
Shilin Wang, Guohong Liu, Yirong Li, Yunbao Pan. Metabolic Reprogramming Induces Macrophage Polarization in the Tumor MicroenvironmentFrontiers in Immunology 2022; 13 doi: 10.3389/fimmu.2022.840029
27
Mohammad Javad Kamali, Mohammad Salehi, Somayeh Fatemi, Fereshteh Moradi, Azin Khoshghiafeh, Mohamadreza Ahmadifard. Locked nucleic acid (LNA): A modern approach to cancer diagnosis and treatmentExperimental Cell Research 2023; 423(1): 113442 doi: 10.1016/j.yexcr.2022.113442
28
Jianying Li, Chelsea Bolyard, Gang Xin, Zihai Li. Targeting Metabolic Pathways of Myeloid Cells Improves Cancer ImmunotherapyFrontiers in Cell and Developmental Biology 2021; 9 doi: 10.3389/fcell.2021.747863
29
Yao Chen, Dong Zhao, Feng Xiao, Xuanyu Li, Jia'an Li, Zhenwei Su, Xingyu Jiang. Microfluidics‐enabled Serial Assembly of Lipid‐siRNA‐sorafenib Nanoparticles for Synergetic Hepatocellular Carcinoma TherapyAdvanced Materials 2023; 35(13) doi: 10.1002/adma.202209672
30
Yukari Shirai, Christalle C. T. Chow, Gouki Kambe, Tatsuya Suwa, Minoru Kobayashi, Itsuki Takahashi, Hiroshi Harada, Jin-Min Nam. An Overview of the Recent Development of Anticancer Agents Targeting the HIF-1 Transcription FactorCancers 2021; 13(11): 2813 doi: 10.3390/cancers13112813